1. Home
  2. SBCF vs DYN Comparison

SBCF vs DYN Comparison

Compare SBCF & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBCF
  • DYN
  • Stock Information
  • Founded
  • SBCF 1926
  • DYN 1984
  • Country
  • SBCF United States
  • DYN United States
  • Employees
  • SBCF N/A
  • DYN N/A
  • Industry
  • SBCF Major Banks
  • DYN Medicinal Chemicals and Botanical Products
  • Sector
  • SBCF Finance
  • DYN Health Care
  • Exchange
  • SBCF Nasdaq
  • DYN Nasdaq
  • Market Cap
  • SBCF 2.4B
  • DYN 2.6B
  • IPO Year
  • SBCF N/A
  • DYN 2020
  • Fundamental
  • Price
  • SBCF $27.08
  • DYN $14.13
  • Analyst Decision
  • SBCF Hold
  • DYN Strong Buy
  • Analyst Count
  • SBCF 5
  • DYN 10
  • Target Price
  • SBCF $28.10
  • DYN $50.70
  • AVG Volume (30 Days)
  • SBCF 401.9K
  • DYN 1.8M
  • Earning Date
  • SBCF 01-27-2025
  • DYN 03-04-2025
  • Dividend Yield
  • SBCF 2.66%
  • DYN N/A
  • EPS Growth
  • SBCF 10.93
  • DYN N/A
  • EPS
  • SBCF 1.36
  • DYN N/A
  • Revenue
  • SBCF $494,135,000.00
  • DYN N/A
  • Revenue This Year
  • SBCF N/A
  • DYN N/A
  • Revenue Next Year
  • SBCF $8.28
  • DYN N/A
  • P/E Ratio
  • SBCF $19.92
  • DYN N/A
  • Revenue Growth
  • SBCF N/A
  • DYN N/A
  • 52 Week Low
  • SBCF $21.90
  • DYN $14.03
  • 52 Week High
  • SBCF $31.68
  • DYN $47.45
  • Technical
  • Relative Strength Index (RSI)
  • SBCF 47.11
  • DYN 19.54
  • Support Level
  • SBCF $26.41
  • DYN $14.79
  • Resistance Level
  • SBCF $27.84
  • DYN $15.90
  • Average True Range (ATR)
  • SBCF 0.75
  • DYN 1.55
  • MACD
  • SBCF 0.07
  • DYN -0.82
  • Stochastic Oscillator
  • SBCF 70.34
  • DYN 0.82

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The Company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage, and credit facilities.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

Share on Social Networks: